News
Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands ...
Although the immediate market response was negative, most pharmaceutical stocks recovered after Wall Street analysts ...
StockStory.org on MSN20h
PFE Q1 Earnings Call: Revenue Misses, Margin Expansion, and Focus on Pipeline ProductivityGlobal pharmaceutical company Pfizer (NYSE:PFE) in Q1 CY2025, with sales falling 7.8% year on year to $13.72 billion. The ...
Income investors have liked Pfizer (NYSE: PFE) for years. However, the big drugmaker's exceptionally juicy dividend these ...
Current polls show former PM Andrej Babiš and his right-wing populist ANO movement leading with 30.7% support.
The company disclosed revenue of $13.7 billion and adjusted earnings of $0.92 per share, compared to consensus estimates of $14.1 billion and $0.68, respectively.
Explore more
14d
Zacks.com on MSNBuy Pfizer (PFE) Stock for a Rebound After Crushing Q1 EPS Expectations?Pfizer (PFE) shares spiked 3% in Tuesday's trading session as the pharmaceutical giant was able to crush its Q1 earnings expectations.
We recently published a list of 13 Stock Predictions That Jim Cramer Got Completely Wrong. In this article, we are going to ...
NEW YORK, April 29, 2025--Pfizer Inc. (NYSE: PFE) reported financial results for the first quarter of 2025 and reaffirmed its 2025 financial guidance(1). NEW YORK, April 26, 2025--Pfizer Inc ...
Like his Big Pharma peers, Pfizer (PFE) CEO Albert Bourla is waiting for the US government to finalize its decision on ...
Pfizer is facing some revenue pressures due to some higher Medicare discounts. Read more to see why I upgrade PFE stock from ...
Pfizer (PFE) stock slips after the company's lower than expected Q1 2025 revenue and the firm seeks acquisitions to boost its obesity pipeline. Read more here.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results